Trial intelligence / Profile preview

Tranexamic acid to reduce postoperative edema and ecchymosis after rhinoplasty

IRCT20200112046095N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in edema and ecchymosis, sponsored by Zahedan University of Medical Sciences. Primary endpoints: Reduction in postoperative edema and Reduction in postoperative ecchymosis. Started Mar 2020; status: completed.

02

Drugs

tranexamic acid
03

Conditions

edemaecchymosis

Beyond the preview

Go deeper on IRCT20200112046095N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200112046095N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call